Cardio-oncology in multiple myeloma: is it time for a specific focus?

Leuk Lymphoma. 2018 Jul;59(7):1764-1766. doi: 10.1080/10428194.2017.1393674. Epub 2017 Oct 31.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Cardiotoxicity
  • Disease Management
  • Heart Diseases / diagnosis
  • Heart Diseases / etiology*
  • Heart Diseases / prevention & control
  • Heart Diseases / therapy
  • Humans
  • Interdisciplinary Research
  • Multiple Myeloma / complications*
  • Multiple Myeloma / drug therapy

Substances

  • Antineoplastic Agents